Diabetes

Significantly better than standard of care at 12 and 24 weeks

This "is a moral issue," Sen. Bernie Sanders said during the hearing

Significantly fewer patients had 3-step worsening of DRSS with oral antiangiogenic

Beta-hydroxybutyrate-based stopping point reduced burden on patients

Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however

Helped diabetics cut down on daily insulin dose, body weight

Small trials show big boost in insulin sensitivity, plus weight loss

But not waiting for repeat glucose-tolerance testing confirmation didn't help mom, trial shows

Diabetic nephropathy was most common of the fatal complications, study showed

Also in TTHealthWatch: umbilical cord blood analysis and obesity

With findings from SURMOUNT-2, Eli Lilly plans to finish FDA submission

Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis

Material deprivation and poor family dynamics during childhood played a role

Health news and commentary from around the Web gathered by MedPage Today staff